PTGX
Protagonist TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
PTGX vs peer average
51/100
PTGX vs. peer average (C vs. C)
Grade spread
A 1 · B 2 · C 3 · D 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
IMVT is the first available peer comparator.
Late-stage biotech with valuation heavily driven by a narrow set of immunology catalysts and balance-sheet runway, making it a useful comparator for milestone concentration and binary-event sensitivity.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PTGX
Protagonist Therapeutics
IMVT
Immunovant
Grade
C
C
Momentum
88
89
Value
48
41
Sentiment
22
38
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs IMVT
PTGX / IMVT
Grade Position
In line
PTGX vs. peer average (C vs. C)
51/100
Momentum
88
IMVTValue
48
PTGXSentiment
22
IMVTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PTGX
IMVT is the first peer returned for this comparison set.